Profile for European Patent Office Patent: 1203761
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2005 00027 | ⤷ Start Trial |
| Netherlands | 300199 | ⤷ Start Trial |
| United Kingdom | SPC/GB05/031 | ⤷ Start Trial |
| Ireland | SPC020/2005 | ⤷ Start Trial |
| Luxembourg | 91182 | ⤷ Start Trial |
| France | 05C0029 | ⤷ Start Trial |
| Switzerland | C01203761/01 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1203761
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
